-
Product Insights
AC Energy Ib Vogt Solar PV Park
AC Energy Ib Vogt Solar PV Park is a solar PV project located in Philippines. The project is owned and being developed by ACEN Corp; ib vogt GmbH. The project is at the permitting stage. Empower your strategies with our AC Energy Ib Vogt Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
Benban Infinity/ib vogt Solar PV 2 Park
Benban Infinity/ib vogt Solar PV 2 Park is a solar PV project located in Aswan, Egypt. The project is owned by BPE Partners; ib vogt GmbH; Infinity Energy SAE and was developed by ib vogt GmbH; Infinity Energy SAE. The project came online in 2019. Empower your strategies with our Benban Infinity/ib vogt Solar PV 2 Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be...
-
Product Insights
Benban Infinity/ib vogt Solar PV 1 Park
Benban Infinity/ib vogt Solar PV 1 Park is a solar PV project located in Aswan, Egypt. The project is owned by BPE Partners; ib vogt GmbH; Infinity Energy SAE and was developed by ib vogt GmbH; Infinity Energy SAE. The project came online in 2019. Empower your strategies with our Benban Infinity/ib vogt Solar PV 1 Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be...
-
Product Insights
DIF Ib Vogt Solar PV Park 2
DIF Ib Vogt Solar PV Park 2 is a solar PV project located in United Kingdom. The project is owned by DIF Capital Partners; Ib Vogt UK Ltd and is developed by Enso Green Holdings Ltd. The project is at the permitting stage. Empower your strategies with our DIF Ib Vogt Solar PV Park 2 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within...
-
Company Insights
Innovation and Patenting activity of AJU IB Investment Co., Ltd. Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of AJU IB Investment Co., Ltd. Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naronapride in Diabetic Gastroparesis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Naronapride in Diabetic Gastroparesis Drug Details: Naronapride is under development for the treatment of multiple...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab in Dedifferentiated Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab in Dedifferentiated Liposarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab in Dedifferentiated Liposarcoma Drug Details: Pembrolizumab (Keytruda) is an antineoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab in Pleomorphic Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab in Pleomorphic Liposarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab in Pleomorphic Liposarcoma Drug Details: Pembrolizumab (Keytruda) is an antineoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab in Ureter Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab in Ureter Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab in Ureter Cancer Drug Details: Pembrolizumab (Keytruda) is an antineoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab in Marginal Zone B-cell Lymphoma Drug Details: Pembrolizumab...